Qing Sun

Dr. Qing Sun


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2022 in Journal of Interferon & Cytokine Research
Verified
Journal Article
Closed access
YZYuli Zhang
Yuli Zhang
JYJianjun Yan
Jianjun Yan
ZLZhengjun Li
Zhengjun Li
JZJuan Zheng
Juan Zheng
QSQing Sun
Qing Sun
Immunomodulatory effects of mesenchymal stem cells (MSCs) in inflammatory diseases, including psoriasis, are well documented. However, the role of MSC-derived exosomes (MSCs-Exo) in psoriasis-like skin inflammation remains largely unknown. This study aimed to investigate whether MSCs-Exo play a regulatory role in psoriasis-like skin inflammation. We found that subcutaneous injection of human umbilical cord MSCs-Exo (hucMSCs-Exo) significantly suppressed the proliferation of epidermis and reduced Psoriasis Area and Severity Index (PASI) scores in imiquimod (IMQ)-induced mice. hucMSCs-Exo also reduced the expression of interleukin (IL)-17, IL-23, and chemokine C-C-motif ligand 20 (CCL20) and inhibited phosphorylation of signal transducer and activator of transcription 3 (STAT3) in the skin of IMQ-induced mice and in human keratinocyte (HaCaT) cells. In addition, co-cultured with hucMSCs-Exo in vitro , the maturation and activation of dendritic cells (DCs) were suppressed, and the expression level of IL-23 was decreased. These results indicate that hucMSCs-Exo can effectively ameliorate psoriasis-like skin inflammation in mice by regulating the expression of IL-23 and IL-17, and inhibiting the maturation and activation of DCs. Our data offer a promising therapeutic approach for psoriasis by leveraging the immunomodulatory effects of hucMSCs-Exo.

1 February 2018 in Experimental Cell Research
Verified
Journal Article
Closed access
MQMeng Qiao
Meng Qiao
RLRonghua Li
Ronghua Li
XZXintong Zhao
Xintong Zhao
JYJianjun Yan
Jianjun Yan
QSQing Sun
Qing Sun

2 October 2018 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
MQMeng Qiao
Meng Qiao
JDJian Ding
Jian Ding
JYJianjun Yan
Jianjun Yan
RLRonghua Li
Ronghua Li
JJJian Jiao
Jian Jiao
QSQing Sun
Qing Sun
Background/Aims: Circular RNAs (circRNAs) are evolutionary conserved circular non-coding RNAs that play a role in several diseases by sequestering (sponging) microRNAs (miRNAs). However, their role in psoriasis remains unclear. In the present study, we investigated the expression of circRNAs and analyzed their potential functions in psoriasis. Methods: The SBC human ceRNA array V1.0 was used to analyze circRNA expression in psoriatic lesions and normal healthy skin tissues. Functional analyses were performed using Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Putative miRNA response elements (MREs) were identified using miRNA target prediction software. Six upregulated circRNAs were verified by quantitative real-time reverse transcription polymerase chain reaction in psoriatic lesions and healthy skin tissues. Results: A total of 4956 circRNAs (3016 upregulated and 1940 downregulated; fold change ≥2 and p< 0.05) were identified as differentially expressed in psoriasis. Furthermore, 4405 MREs were identified among the differentially expressed circRNAs. hsa_circ_0061012 was upregulated in psoriatic lesions compared with normal healthy skin tissues. The top five MREs of hsa_circ_0061012 were hsa-miR-7157-5p, hsa-miR-4769-3p, hsa-miR-6817-5p, hsa-miR-4310, and hsa-miR-6882-3p. GO analysis was carried out to investigate the biological functions enriched among the upregulated targets of five miRNAs in psoriasis. The GO analysis identified that most of top 30 of GO enrichment are related to psoriasis. Conclusion: hsa_circ_0061012 might be a candidate biomarker for psoriasis. The results provide a new perspective for a better understanding of ceRNA-mediated gene regulation in psoriasis, and provide a novel theoretical basis for further studies on the function of circRNA in psoriasis.

23 November 2016 in Photodermatology, Photoimmunology & Photomedicine
Verified
Journal Article
Closed access
PDF file
RLRonghua Li
Ronghua Li
MQMeng Qiao
Meng Qiao
XWXiaoyan Wang
Xiaoyan Wang
XZXintong Zhao
Xintong Zhao
QSQing Sun
Qing Sun

30 September 2018 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JYJ.J. Yan
J.J. Yan
MQM. Qiao
M. Qiao
RLR.H. Li
R.H. Li
XZX.T. Zhao
X.T. Zhao
XWX.Y. Wang
X.Y. Wang
QSQing Sun
Qing Sun

1 January 2021 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
YHYuexi He
Yuexi He
XYXiran Yin
Xiran Yin
JYJianjun Yan
Jianjun Yan
XLXue Li
Xue Li
QSQing Sun
Qing Sun
Background. The pathogenesis of long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) are well studied in psoriasis. However, little is known about how specific lncRNAs and miRNAs affect the mechanism of psoriasis development and which pathways are involved. Objectives. To explore the role of the lncRNA H19/miR‐766‐3p/S1PR3 axis in psoriasis. Methods. miRNA and lncRNA microarrays were performed using IL‐22‐induced HaCaT cells and psoriatic lesions, respectively. Fluorescence in situ hybridization and quantitative reverse‐transcriptase polymerase chain reaction were used to detect the expression of miR‐766‐3p and lncRNA H19. Luciferase reporter assays were used to identify miR‐766‐3p/lncRNA H19 and miR‐766‐3p/S1PR3 combinations. CCK‐8 and ELISA were performed to evaluate the proliferation of keratinocytes and the secretion of pro‐inflammatory cytokines. Western blot analysis was used to detect the expression of S1PR3 and its downstream effector proteins. Results. MiR‐766‐3p was upregulated in both HaCaT cells treated with the psoriasis‐related cytokine pool (IL‐17A, IL‐22, IL‐1 alpha, oncostatin M, and TNF‐alpha) and tissues. Overexpression of miR‐766‐3p promoted keratinocyte proliferation and IL‐17A and IL‐22 secretion. LncRNA H19 and S1PR3 were demonstrably combined with miR‐766‐3p by luciferase reporter assay. lncRNA H19 repressed proliferation and inflammation, which were reduced by the miR‐766‐3p. AKT/mTOR pathway effected proliferation and inflammation by the lncRNA H19/miR‐766‐3p/S1PR3 axis. Conclusions. We established that downregulation of lncRNA H19 promoted the proliferation of keratinocytes and skin inflammation by up‐regulating miR‐766‐3p expression levels and inhibiting activation of S1PR3 through the AKT/mTOR pathway in psoriasis.